Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.23 USD | +0.59% | -5.62% | -27.01% |
05-08 | Olema Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-02 | Goldman Sachs Initiates Olema Pharmaceuticals at Buy With $24 Price Target | MT |